TABLE 2 Clinical Findings of Cases of CCSK and MRT

From: Infrequent p53 Gene Mutations and Lack of p53 Protein Expression in Clear Cell Sarcoma of the Kidney: Immunohistochemical Study and Mutation Analysis of p53 in Renal Tumors of Unfavorable Prognosis

Case

Age (yr)/Sex

Diagnosis

Kidney

Clinical Stage

Therapy

Outcome

1

1/F

CCSK

Right

I

S, CT

No recurrence for 7 years

2

8/M

CCSK

Right

III

S, CT, RT

Died 21/2 years later with liver and lung metastases

3

18/F

CCSK

Left

II

S, CT

No follow-up data available

4

7/F

CCSK

Right

III

S, CT, RT

No recurrence for 10 years

5

2/M

CCSK

Right

III

S, CT, RT

No recurrence for 9 years

6

2 mo/M

CCSK

Left

I

S, CT

No recurrence for 7 years

7

4/M

CCSK

Left

II

S, CT

Died 31/2 years later with bone and lung metastases

8

12/M

CCSK

Right

II

S, CT

No recurrence for 31/2 years

9

Newborn/M

MRTK

Right

IV

S, CT

Died 6 months later with skin and lung metastases

  1. S, surgery; CT, chemotherapy; RT, radiotherapy.